Week 9 and beyond: Adjust to the target maintenance dose, which may range from 3 mg to 6 mg once weekly
En resumen, el cerebro recibe antes el mensaje de saciedad
Similar to tirzepatide, retatrutides activation of GLP-1 and GIP receptors promotes insulin secretion, decelerates digestion, and reduces appetite, contributing to notable weight loss [6, 7, 8]
For example, those on the lowest dose lost about 8.7% of their weight, while those on the highest dose lost 24.2%
Inject the missed dose as soon as you remember it, provided fewer than 4 days have elapsed since the scheduled day
The significant weight loss achieved with GLP-1 therapy varies by agent and dosewith semaglutide 2.4mg (Wegovy) achieving approximately 15% body weight reduction at 68 weeks, while liraglutide 3mg (Saxenda) typically produces 5-8% weight loss